Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • and disease (1)
  • antigens (2)
  • b virus (1)
  • d c (1)
  • female (1)
  • glycoprotein (1)
  • hbsag (22)
  • humans (1)
  • n 30 (1)
  • patients (5)
  • Sizes of these terms reflect their relevance to your search.

    Increasing evidences suggest that HBsAg-production varies across HBV-genotypes. HBsAg C-terminus plays a crucial role for HBsAg-secretion. Here, we evaluate HBsAg-levels in different HBV-genotypes in HBeAg-negative chronic infection, the correlation of specific mutations in HBsAg C-terminus with HBsAg-levels in-vivo, their impact on HBsAg-secretion in-vitro and on structural stability in-silico.HBsAg-levels were investigated in 323 drug-naïve HBeAg-negative patients chronically infected with HBV genotype-D(N = 228), -A(N = 65) and -E(N = 30). Genotype-D was characterized by HBsAg-levels lower than genotype-A and -E (3.3[2.7-3.8]IU/ml; 3.8[3.5-4.2]IU/ml and 3.9[3.7-4.2]IU/ml, P < 0.001). Results confirmed by multivariable analysis correcting for patients'demographics, HBV-DNA, ALT and infection-status.In genotype-D, specific C-terminus mutations (V190A-S204N-Y206C-Y206F-S210N) significantly correlate with HBsAg<1000IU/ml(P-value from <0.001 to 0.04). These mutations lie in divergent pathways involving other HBsAg C-terminus mutations: V190A + F220L (Phi = 0.41, P = 0.003), S204N + L205P (Phi = 0.36, P = 0.005), Y206F + S210R (Phi = 0.47, P < 0.001) and S210N + F220L (Phi = 0.40, P = 0.006). Notably, patients with these mutational pairs present HBsAg-levels 1log lower than patients without them(P-value from 0.003 to 0.02). In-vitro, the above-mentioned mutational pairs determined a significant decrease in HBsAg secretion-efficiency compared to wt(P-value from <0.001 to 0.02). Structurally, these mutational pairs reduced HBsAg C-terminus stability and determined a rearrangement of this domain.In conclusion, HBsAg-levels in genotype-D are significantly lower than in genotype-A and -E in HBeAg-negative patients. In genotype-D, specific mutational clusters in HBsAg C-terminus correlate with lower HBsAg-levels in-vivo, hamper HBsAg-release in-vitro and affect its structural stability, supporting their detrimental role on HBsAg-secretion. In this light, genotypic-testing can be a valuable tool to optimize the clinical interpretation of HBsAg in genotype-D and to provide information on HBV-pathogenicity and disease-progression.

    Citation

    Romina Salpini, Arianna Battisti, Lorenzo Piermatteo, Luca Carioti, Olympia E Anastasiou, Upkar S Gill, Domenico Di Carlo, Luna Colagrossi, Leonardo Duca, Ada Bertoli, Katia Yu La Rosa, Lavinia Fabeni, Alessandra Iuvara, Vincenzo Malagnino, Carlotta Cerva, Miriam Lichtner, Claudio M Mastroianni, Giuseppe Maria De Sanctis, Maurizio Paoloni, Massimo Marignani, Caterina Pasquazzi, Nerio Iapadre, Giustino Parruti, Jacopo Vecchiet, Loredana Sarmati, Massimo Andreoni, Mario Angelico, Sandro Grelli, Patrick T Kennedy, Jens Verheyen, Stefano Aquaro, Francesca Ceccherini Silberstein, Carlo Federico Perno, Valentina Svicher. Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection. Emerging microbes & infections. 2020 Dec;9(1):928-939

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32312174

    View Full Text